Biotechnology AIM Immunotech FDA Lifts Hold, Stock Surges 25%By MohamedMis2July 29, 2023 In a significant development, the FDA has recently lifted its hold on AIM Immunotech. Resulting in a remarkable 25% surge…
Asset Management OPAL Beats EPS Estimates, Misses RevenueBy MohamedMis2July 21, 2023 Shares of OPAL surged today after the company announced earnings that beat expectations, despite missing on revenue. OPAL announced their…
